Clinical Trials Directory

Trials / Terminated

TerminatedNCT00870701

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Randomised Multicentric Phase III Study Comparing Observation Versus Post-surgery Radiotherapy After Complete Exeresis With Margins Greater Than or Equal to 1 cm in Soft Tissues Members Sarcoma.

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Institut Claudius Regaud · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Soft tissue sarcomas represent less than 1% of malignant tumors in adults and sarcomas members represent 60% of them. These rare tumors involve complex multidisciplinary care better in centers having expertise. Loco-regional therapy strategies have evaluated over time for tumors of members leading to propose more often the combination of a large conservative tumor excision with radiotherapy. Results have been demonstrated equivalent to those of an amputation in terms of local control and survival. The local recurrence rate for sarcomas of the members of any kind after surgery with or without radiotherapy in the literature varies from 10 to 30%. The main objective is to achieve a low recurrence rate while maintaining the function. The question remains the possibility of an absence of irradiation in selected cases in a de-escalation therapy order.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiotherapy50 grays in 25 fractions of 2 Gys or 50.4 grays in 28 fractions of 1.8 grays
OTHERabsence of radiotherapyabsence of radiotherapy

Timeline

Start date
2009-03-19
Primary completion
2017-03-10
Completion
2017-03-10
First posted
2009-03-27
Last updated
2018-08-22

Locations

18 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00870701. Inclusion in this directory is not an endorsement.